Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
agalsidase beta (Fabrazyme) (1 trial)
Zalunfiban (1 trial)
Coronary Disease (Phase 1)
Fabry Disease (Phase 2)
Kidney Diseases (Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Trials (2 total)
Trial APIs (2 total)